Mechanistically, CX-chemokine ligand 5 (CXCL5) derived by α-SMA+ CAFs enhances the expression of PD-L1 in tumor cells by activating PI3K/AKT signaling pathway [90]. This evidence concerns the gene ACTA1 and neoplasm.